S. Woods

发表

Integrated Systems and Technologies Hyperpolarized [ 1-13 C ] Glutamate : A Metabolic Imaging Biomarker of IDH 1 Mutational Status in Glioma

P. Larson, S. Nelson, D. Vigneron, 2014 .

In vivo comparison of total and hyperpolarized lactate levels assessed by localized 1 H MRS and hyperpolarized 13 C MRSI in glioblastoma models at 14 . 1 Tesla

Aaron E. Robinson, M. Chaumeil, S. Ronen, 2011 .

Treatment with the MEK inhibitor U0126 induces decreased hyperpolarized pyruvate to lactate conversion in breast, but not prostate, cancer cells

S. Ronen, A. Lodi, S. Woods, 2013, NMR in biomedicine.

BI-07HYPERPOLARIZED [1-13C] GLUTAMATE: A METABOLIC IMAGING BIOMARKER OF IDH1 MUTATIONAL STATUS IN GLIOMA.

P. Larson, S. Nelson, D. Vigneron, 2014 .

Hyperpolarized [1-13C] glutamate: a metabolic imaging biomarker of IDH1 mutational status in glioma.

P. Larson, S. Nelson, D. Vigneron, 2014, Cancer research.

Metabolic consequences of treatment with AKT inhibitor perifosine in breast cancer cells

S. Ronen, S. Woods, J. Su, 2012, NMR in biomedicine.

MR‐detectable metabolic consequences of mitogen‐activated protein kinase kinase (MEK) inhibition

S. Ronen, A. Lodi, S. Woods, 2014, NMR in biomedicine.

Non-invasive assessment of IDH status in glioblastoma using dynamic 13 C MRS of hyperpolarized α-ketoglutarate

Aaron E. Robinson, M. Chaumeil, S. Ronen, 2011 .